Newswise — The integrated Translational Health Research Institute of Virginia (iTHRIV) has awarded funding to four multi-institutional research projects through the Pilot Translational and Clinical Studies Program. By providing seed grant funding to support early phase research projects, the program is intended to accelerate joint discovery and the application of translational medical research.
Teams comprised of physicians, researchers, and engineers at the University of Virginia, Virginia Tech, Carilion Clinic, and Inova Health System were awarded up to $50,000 in funding.
“A novel biomarker for hereditary angioedema with implications for common vascular disorders”
Led by Clint Miller, an assistant professor at the University of Virginia School of Medicine, and Natalie Hauser, a physician at the Inova Health System, this project will address a potentially life-threatening set of disorders characterized by recurrent swelling called hereditary angioedema (HAE). The team has identified a new genetic mutation associated with HAE and will investigate the effects of this mutation on blood-vessel function, which could lead to improved diagnosis and treatment of the disease as well as other vascular and heart diseases.
Congrats to our Southern friends!
iTHRIV, the Integrated Translational Health Research Institute of Virginia, has received nearly $23 million in support from the National Institutes of Health's Clinical and Translational Science Awards (CTSA) program.
Based at UVA, iTHRIV is a statewide collaboration that aims to promote interdisciplinary research, with the goal of translating scientific discoveries into new treatments and enhancing how doctors provide care. It seeks to improve the process of research and to benefit underserved populations.
Visit iTHRIV online at www.ithriv.org.
Read more at www.newswise.com.
NC TraCS director Dr. John Buse quoted in diabetes story on NBC News
May 28, 2019, 3:43 PM EDT / By Associated Press
The number of new diabetes cases among U.S. adults keeps falling, even as obesity rates climb, and health officials aren't sure why.
New federal data released Tuesday found the number of new diabetes diagnoses fell to about 1.3 million in 2017, down from 1.7 million in 2009.
Earlier research had spotted a decline, and the new report shows it's been going on for close to a decade. But health officials are not celebrating.